CVS HEALTH CORPORATION Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings
CVS HEALTH CORPORATION (CVS) reported Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings of -$24.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings · last filed 2022-02-09
- CVS HEALTH CORPORATION other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2019-12-31 was -$46.00M.
- CVS HEALTH CORPORATION other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2019-09-30 was $9.00M.
- CVS HEALTH CORPORATION other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2019-06-30 was $6.00M.
- CVS HEALTH CORPORATION other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2019-03-31 was $7.00M.
- CVS HEALTH CORPORATION other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2019 was -$24.00M.
- CVS HEALTH CORPORATION other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2018 was $0.00.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 3 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 6 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 9 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | -$37.00M derived: sum of 2 quarters · filed 2022-02-09 | -$31.00M derived: sum of 3 quarters · filed 2022-02-09 | -$24.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $9.00M 10-Q · filed 2020-11-06 | $15.00M derived: sum of 2 quarters · filed 2020-11-06 | $22.00M 10-Q · filed 2020-11-06 | $22.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $6.00M 10-Q · filed 2020-08-05 | $13.00M 10-Q · filed 2020-08-05 | $13.00M derived: sum of 3 quarters · filed 2021-02-16 | $13.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $7.00M 10-Q · filed 2020-05-06 | $7.00M derived: sum of 2 quarters · filed 2021-02-16 | $7.00M derived: sum of 3 quarters · filed 2021-02-16 | $7.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $0.00 derived: sum of 2 quarters · filed 2021-02-16 | $0.00 derived: sum of 3 quarters · filed 2021-02-16 | $0.00 10-K · filed 2021-02-16 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |